Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Baseline Features and CHA2DS2 VASc /HAS BLED Scores of Jordanian Patients With Atrial Fibrillation and the One Year Outcome

NCT03917992 is registered in ClinicalTrials.gov with Ayman J Hammoudeh, MD, FACC as lead sponsor.

NCT NCT03917992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03917992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Baseline Features and CHA2DS2 VASc /HAS BLED Scores of Jordanian Patients With Atrial Fibrillation and the One Year Outcome
Lead sponsor
Ayman J Hammoudeh, MD, FACC
Phase
Observational
Overall status
Completed
Start date
May 25, 2019
Completion date
November 25, 2021
Enrollment
2,020 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation